0,1,2,3,4,5,6,7
Table 7:  Procedure-specific evidence summaries with recommendations for primary nerve sparing,,,,,,,
Procedure,Outcome,"Baseline risk 
among 1000 
patients",,"Net benefit per 
1000 patients 
with pharma-
cological 
prophylaxis*","Certainty 
in 
estimate","Recommendations 
for pharma-
cological 
prophylaxis","Recommendations 
for mechanical 
prophylaxis"
"Primary 
nerve sparing 
retroperitoneal 
lymph node 
dissection","Venous 
thrombo-
embolism",Low-risk,23,10,Very low,Weak - for,Weak – for
,,Medium-risk,45,21,Very low,Weak - for,Weak – for
,,High-risk,91,44,Very low,Weak - for,Weak - for
,"Bleeding 
requiring 
reoperation",,2.0,,Very low,,
